US EditionPublished • loading... • Updated
Crispr Therapies: What Is the Actual Status of Genome Editing to Treat the Sick?
Summary by Numerama
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
What looked like science fiction yesterday is now a clinical reality: the publishing of the human genome with CRISPR-Cas9 begins to cure diseases that have hitherto been incurable. But what is the actual status of this announced revolution? Between first clinical successes, technical limitations and persistent ethical issues, the therapies from CRISPR draw a landscape where promises and prudence are now inseparable.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
